Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 866.00
-13.00 (-1.48%)
Aug 6, 2026, 10:45 AM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 81.41 billion as of August 5, 2026. Its market cap has decreased by -3.87% in one year.
Market Cap
81.41B
Enterprise Value
125.64B
Revenue
34.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
866.00
ChartMarket Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 81.41B, an increase of 112.02%. That is a compound annual growth rate of 3.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 81.41B | 8.77% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 163.72B |
| PeptiDream | 119.93B |
| Oncolys BioPharma | 78.24B |
| SanBio Company | 71.58B |
| Heartseed | 38.20B |
| Cuorips | 37.45B |
| Healios K.K. | 31.73B |
| Japan Tissue Engineering | 28.63B |